Parp Inhibitor Biomarkers Market
PARP Inhibitor Biomarkers Market Research Report: By Cancer Type (Breast Cancer, Ovarian Cancer, Prostate Cancer, Lung Cancer, Other Cancers), By Biomarker Type (BRCA Mutations, PARP Expression, HRD Score, Other Biomarkers), By Application (Diagnosis, Prognosis, Treatment Selection, Monitoring, Other Applications), By End User (Hospitals, Diagnostic Laboratories, Pharmaceutical Companies, Research Institutions, Other End Users), By Technology (Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH), Digital PCR, Other Technologies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032
Global PARP Inhibitor Biomarkers Market Overview
As per MRFR analysis, the PARP Inhibitor Biomarkers Market Size was estimated at 2.64 (USD Billion) in 2022.ย The PARP Inhibitor Biomarkers Market Industry is expected to grow from 3.0(USD Billion) i..